Common Contracts
11 similar Investors’ Rights Agreement contracts by Allena Pharmaceuticals, Inc., Zendesk, Inc., Acacia Communications, Inc., others
NKARTA, INC. AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT August 27, 2019Investors’ Rights Agreement • June 19th, 2020 • Nkarta, Inc. • Pharmaceutical preparations • Delaware
THIS AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”), is made as of the 27th day of August, 2019, by and among Nkarta, Inc., a Delaware corporation (the “Company”), and each of the investors listed on Schedule A hereto (together with any subsequent investors or transferees who become parties to this Agreement in accordance with Section 6.9 hereof, each an “Investor” and together the “Investors”).
EX-4.2 6 d431688dex42.htm EX-4.2 Execution Version Allena Pharmaceuticals, Inc. SECOND AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT Page - i - Schedule A – Schedule of Investors - ii - SECOND AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • May 5th, 2020 • Delaware
THIS SECOND AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”) is made as of the 25th day of November, 2015 by and among Allena Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and each of the investors listed on Schedule A hereto (together with any subsequent investors, or transferees, who become parties hereto as “Investors” pursuant to Section 6.9 below, the “Investors”).
EX-4 4 filename4.htm EXECUTION VERSION ACACIA COMMUNICATIONS, INC. AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT April 17, 2013 Page Schedule A - Schedule of Investors AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • May 5th, 2020 • Delaware
THIS AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT is made as of the 17th day of April, 2013 by and among Acacia Communications, Inc., a Delaware corporation (the “Company”), and the investors listed on Schedule A hereto (each of which individually is referred to in this Agreement as an “Investor” and collectively as the “Investors”).
Allena Pharmaceuticals, Inc. SECOND AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • October 6th, 2017 • Allena Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Delaware
THIS SECOND AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”) is made as of the 25th day of November, 2015 by and among Allena Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and each of the investors listed on Schedule A hereto (together with any subsequent investors, or transferees, who become parties hereto as “Investors” pursuant to Section 6.9 below, the “Investors”).
Allena Pharmaceuticals, Inc. SECOND AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • August 18th, 2017 • Allena Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Delaware
THIS SECOND AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”) is made as of the 25th day of November, 2015 by and among Allena Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and each of the investors listed on Schedule A hereto (together with any subsequent investors, or transferees, who become parties hereto as “Investors” pursuant to Section 6.9 below, the “Investors”).
ACACIA COMMUNICATIONS, INC. AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT April 17, 2013Investors’ Rights Agreement • August 27th, 2015 • Acacia Communications, Inc. • Semiconductors & related devices • Delaware
THIS AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT is made as of the 17th day of April, 2013 by and among Acacia Communications, Inc., a Delaware corporation (the “Company”), and the investors listed on Schedule A hereto (each of which individually is referred to in this Agreement as an “Investor” and collectively as the “Investors”).
SECOND AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • March 30th, 2015 • CoLucid Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
THIS SECOND AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”) is made as of the 12th day of January, 2015, by and among CoLucid Pharmaceuticals, Inc., a Delaware corporation (the “Company”), each of the investors listed on Schedule A hereto (each a “Series A Investor” and collectively, the “Series A Investors”), each of the investors listed on Schedule B hereto (each a “Series B Investor” and collectively, the “Series B Investors”) and each of the investors listed on Schedule C hereto (each a “Series C Investor” and collectively, the “Series C Investors”). The Series A Investors, Series B Investors and Series C Investors are referred to herein individually as an “Investor” and collectively as the “Investors.”
THIRD AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT BY AND AMONG ZAFGEN, INC. AND THE INVESTORS NAMED HEREIN November 25, 2013Investors’ Rights Agreement • April 18th, 2014 • Zafgen, Inc. • Pharmaceutical preparations • Delaware
THIS THIRD AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”) is made as of November 25, 2013, by and between Zafgen, Inc., a Delaware corporation (the “Company”), and each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor” and any additional Investor that becomes a party to this Agreement in accordance with Section 6.9 hereof.
ZENDESK, INC. THIRD AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT SEPTEMBER 5, 2012Investors’ Rights Agreement • April 10th, 2014 • Zendesk, Inc. • Services-computer processing & data preparation • Delaware
THIS THIRD AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”) is made and entered into as of September 5, 2012, by and among Zendesk, Inc., a Delaware corporation (including its predecessors, the “Company”), and each of the investors listed on Schedule A hereto (each, an “Investor,” and collectively, the “Investors”).
FOURTH AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • March 4th, 2014 • Akebia Therapeutics, Inc. • Pharmaceutical preparations • Delaware
THIS FOURTH AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”) is made as of the [—] day of February, 2014 by and among AKEBIA THERAPEUTICS, INC., a Delaware corporation (the “Company”), each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor” and collectively, the “Investors”), and any Additional Investor that becomes a party to this Agreement in accordance with Section 6.9 hereof.
ZENDESK, INC. THIRD AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT SEPTEMBER 5, 2012Investors’ Rights Agreement • February 14th, 2014 • Zendesk, Inc. • Services-computer processing & data preparation • Delaware
THIS THIRD AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”) is made and entered into as of September 5, 2012, by and among Zendesk, Inc., a Delaware corporation (including its predecessors, the “Company”), and each of the investors listed on Schedule A hereto (each, an “Investor,” and collectively, the “Investors”).
